Skip to main content

Endocrine Control and Regulation of Growth Hormone: An Overview

  • Chapter
  • First Online:
Handbook of Growth and Growth Monitoring in Health and Disease
  • 568 Accesses

Abstract

The control of growth hormone (GH) production is complex, partly because GH serves both metabolic and anabolic roles. GH exerts potent anti-insulin effects at hepatic and peripheral sites and increases fat mobilization and lipolysis. IGF-I, a critical growth factor induced by GH, is likely responsible for most anabolic (on lean mass and bone mineralization) and growth-promoting (on growth plate) activities of GH, which also requires sufficient energy stores. GH secretion is regulated by hypothalamic growth hormone-releasing hormone (GHRH) and somatostatin interacting with circulating hormones, metabolic regulators, neurotransmitters, and additional modulatory peptides at the level of both the pituitary and the hypothalamus. Age, puberty, gender, sleep, exercise, food intake, and body composition are physiological determinants of GH secretion. Numerous hormones (ghrelin, sex steroids, glucocorticoids, thyroid hormones, insulin, glucagon, leptin, GH itself, and IGF-1) and metabolic regulators (glucose, amino acids, free fatty acids) control GH. “Normal” GH secretion covers a broad range of GH concentrations, and the definition of thresholds for GH deficiency following stimulation tests or integrated GH concentration measurement over 24 h proves to be difficult. There is no gold standard for GHD diagnosis, which relies on medical history, auxology, IGF-1/IGFBP3 measurements, GH provocative tests, and magnetic resonance imaging findings.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 429.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 549.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ALS:

Acid-labile subunit

BMI:

Body mass index

GH:

Growth hormone

GHBP:

Growth hormone-binding protein

GHD:

Growth hormone deficiency

GHR:

GH receptor

GHRH:

Growth hormone-releasing hormone

GHRP:

GH-releasing peptides

GHS-R:

Growth hormone secretagogue receptor

GPCR:

G protein-coupled receptor

IGF-I:

Insulin-like growth factor I

IGFBP:

IGF-binding protein

JAK:

Janus kinase

rhGH:

Recombinant human growth hormone

SGA:

Small for gestational age

SOCS:

Suppressors of cytokine signaling

SSTR:

Somatostatin receptor

STAT:

Signal transducers and activators of transcription

References

  • Besson A, Salemi S, Deladoey J, Vuissoz JM, Eble A, Fluck C, Mullis PE. Short stature caused by a biologically inactive mutant growth hormone (GH-C53S). J Clin Endocrinol Metab. 2005;90:2493–9.

    Article  PubMed  CAS  Google Scholar 

  • Bougneres P. The exon-3 deletion of the growth hormone receptor (GHR) gene still has a limited impact in clinical endocrinology. J Clin Endocrinol Metab. 2010;95:56–9.

    Article  PubMed  CAS  Google Scholar 

  • Bowers CY. Unnatural growth hormone-releasing peptide begets natural ghrelin. J Clin Endocrinol Metab. 2001;86:1464–9.

    Article  PubMed  CAS  Google Scholar 

  • Carel JC, Tresca JP, Letrait M, Chaussain JL, Lebouc Y, Job JC, Coste J. Growth hormone testing for the diagnosis of growth hormone deficiency in childhood: a population register-based study. J Clin Endocrinol Metab. 1997;82:2117–21.

    Article  PubMed  CAS  Google Scholar 

  • Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B. A mutation in the leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398–401.

    Article  PubMed  CAS  Google Scholar 

  • Coutant R, Boux de Casson F, Douay O, Mathieu E, Rouleau S, Beringue F, Gillard P, Limal JM, Descamps P. Relationships between placental GH concentration and maternal smoking, newborn gender, and maternal leptin: possible implications for birth weight. J Clin Endocrinol Metab 2001;86:4854–9.

    Article  PubMed  CAS  Google Scholar 

  • Coutant R, Lahlou N, Bouvattier C, Bougneres P. Circulating leptin level and growth hormone response to stimulation tests in obese and normal children. Eur J Endocrinol. 1998;139:591–7.

    Article  PubMed  CAS  Google Scholar 

  • GH Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab. 2000;85:3990–93.

    Article  Google Scholar 

  • Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev. 1998;19:717–97.

    Article  PubMed  CAS  Google Scholar 

  • Goddard AD, Covello R, Luoh SM, Clackson T, Attie KM, Gesundheit N, Rundle AC, Wells JA, Carlsson LM. Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group. N Engl J Med. 1995;333:1093–8.

    Article  PubMed  CAS  Google Scholar 

  • Hill DJ, Riley SC, Bassett NS, Waters MJ. Localization of the growth hormone receptor, identified by immunocytochemistry, in second trimester human fetal tissues and in placenta throughout gestation. J Clin Endocrinol Metab. 1992;75:646–50.

    Article  PubMed  CAS  Google Scholar 

  • Iranmanesh A, Lizarralde G, Veldhuis J. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab. 1991;73:1081–8.

    Article  PubMed  CAS  Google Scholar 

  • Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, Pratt KL, Bezrodnik L, Jasper H, Tepper A, Heinrich J, Rosenfeld RG. Growth-hormone insensitivity (GHI) associated with a STAT-5b mutation. N Engl J Med. 2003;349:1139–47.

    Article  PubMed  CAS  Google Scholar 

  • Kojima M, Hosada H, Data Y, Nakazato M, Matsuo H, Kankawa K. Ghrelin is a growth-hormone releasing acylated peptide from stomach. Nature 1999;402:656–60.

    Article  PubMed  CAS  Google Scholar 

  • Kopchick JJ, Parkinson C, Stevens EC, Trainer PJ. Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly. Endocr Rev. 2002;23:623–46.

    Article  PubMed  CAS  Google Scholar 

  • Kowarski AA, Schneider J, Ben-Galim E, Weldon VV, Daughaday WH. Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH. J Clin Endocrinol Metab. 1978;72:461–4.

    Article  Google Scholar 

  • Leger J, Oury JF, Noel M, Baron S, Benali K, Blot P, Czernichow P. Growth factors and intrauterine growth retardation. I. Serum growth hormone, insulin-like growth factor (IGF)-I, IGF-II, and IGF binding protein 3 levels in normally grown and growth-retarded human fetuses during the second half of gestation. Pediatr Res. 1996;40:94–100.

    Article  PubMed  CAS  Google Scholar 

  • Marin G, Domene H, Barnes K, Blackwell B, Cassorla F, Cutler G, Jr. The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. J Clin Endocrinol Metab. 1994;79:537–41.

    Article  PubMed  CAS  Google Scholar 

  • Martinez AS, Domene HM, Ropelato MG, Jasper HG, Pennisi PA, Escobar ME, Heinrich JJ. Estrogen priming effect on growth hormone (GH) provocative test: a useful tool for the diagnosis of GH deficiency. J Clin Endocrinol Metab. 2000;85:4168–72.

    Article  PubMed  CAS  Google Scholar 

  • Mulchahey JJ, DiBlasio AM, Martin MC, Blumenfeld Z, Jaffe RB. Hormone production and peptide regulation of the human fetal pituitary gland. Endocr Rev. 1987;8:406–25.

    Article  PubMed  CAS  Google Scholar 

  • Pantel J, Legendre M, Cabrol S, Hilal L, Hajaji Y, Morisset S, Nivot S, Vie-Luton M-P, Grouselle D, de Kerdanet M, Kadiri A, Epelbaum J, Le Bouc Y, Amselem S. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J Clin Invest. 2006;116:760–8.

    Article  PubMed  CAS  Google Scholar 

  • Pinto G, Netchine I, Sobrier ML, Brunelle F, Souberbielle JC, Brauner R. Pituitary stalk interruption syndrome: a clinical-biological-genetic assessment of its pathogenesis. J Clin Endocrinol Metab. 1997;82:3450–4.

    Article  PubMed  CAS  Google Scholar 

  • Reiter EW, Rosenfeld RG. Normal and aberrant growth. In: Larsen PR, Kronenberg HM, Melmed S, Polonski KS, editors. Williams textbook of endocrinology. 10th ed. Philadelphia, PA: Saunders; 2003. pp. 1003–14.

    Google Scholar 

  • Rochiccioli P, Enjaume C, Tauber MT, Pienkowski C. Statistical study of 5473 results of nine pharmacological stimulation tests: a proposed weighting index. Acta Paediatr. 1993;82:245–8.

    Article  PubMed  CAS  Google Scholar 

  • Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev. 1994;15:369–90.

    PubMed  CAS  Google Scholar 

  • Takahashi Y, Shirono H, Arisaka O, Takahashi K, Yagi T, Koga J, Kaji H, Okimura Y, Abe H, Tanaka T, Chihara K. Biologically inactive growth hormone caused by an amino acid substitution. J Clin Invest. 1997;100:1159–65.

    Article  PubMed  CAS  Google Scholar 

  • Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb BD. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001;29:465–8.

    Article  PubMed  CAS  Google Scholar 

  • Toogood AA, Nass RM, Pezzoli SS, O’Neill PA, Thorner MO, Shalet SM. Preservation of growth hormone pulsatility despite pituitary pathology, surgery, and irradiation. J Clin Endocrinol Metab. 1997;82:2215–21.

    Article  PubMed  CAS  Google Scholar 

  • Waters MJ, Kaye PL. The role of growth hormone in fetal development. GH and IGF Res. 2002;12:137–46.

    CAS  Google Scholar 

  • Zadik Z, Chalew SA, McCarter RJ, Jr., Meistas M, Kowarski AA. Assessment of growth hormone secretion in normal stature children using 24-hour integrated concentration of GH and pharmacological stimulation. J Clin Endocrinol Metab. 1985;60:513–6.

    Article  PubMed  CAS  Google Scholar 

  • Zadik Z, Chalew SA, Kowarski A. The influence of age of 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab. 1990;71:932–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Coutant .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Coutant, R., Bouhours-Nouet, N. (2012). Endocrine Control and Regulation of Growth Hormone: An Overview. In: Preedy, V. (eds) Handbook of Growth and Growth Monitoring in Health and Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1795-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1795-9_5

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1794-2

  • Online ISBN: 978-1-4419-1795-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics